Post Marketing Surveillance (PMS) is a critical component in the epidemiological framework that involves the monitoring of pharmaceutical products after they have been released to the market. This process is crucial for ensuring the continued safety and efficacy of medications and medical devices. PMS aims to identify any adverse reactions or long-term effects that were not apparent in pre-market clinical trials.
